An initial cohort of 15 patients has reached the two-year mark in an ongoing clinical trial for a posterior dynamic stabilization device designed to support an injured or degenerative spine without eliminating motion, according a release from the maker, Applied Spine Technologies.
The company added that the Stabilimax Dynamic Spine Stabilization System has also received FDA permission to resume a multi-center, randomized, controlled clinical trial, comparing posterior dynamic stabilization with the system to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis.
The company has enrolled more than 100 patients in the trials to date.
Read the release about the Applied Spine posterior dynamic stabilization device.
The highest-paid CEOs at spine and orthopedic medtech companies saw total compensation of more than $20 million. Here is how…
Elon Musk’s brain-implant company, Neuralink, may soon have a new competitor in the market. Neurotechnology startup Precision Neuroscience has earned…
Alphatec CEO Patrick Miles earned about $6.2 million in total compensation, according to the company’s April 11 Securities and Exchange…
Comments are closed.